BREO ELLIPTA (fluticasone furoate; vilanterol trifenatate) Glaxo grp ltd Patent: 7,776,895 Expiration: Sep 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations for …
Drug Patent Expirations for the Week of September 11, 2022 Read Post »
Annual Drug Patent Expirations for CIPRODEX Ciprodex is a drug marketed by Novartis and is included in one NDA. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Novartis drug CIPRODEX appeared …
New patent expiration for Novartis drug CIPRODEX Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug T…
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug T…
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug ANORO…
New patent expiration for Glaxosmithkline drug ANORO ELLIPTA Read Post »
Annual Drug Patent Expirations for ORAVIG Oravig is a drug marketed by Galt Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Galt Pharms drug ORAVIG appeared first on Drug…
New patent expiration for Galt Pharms drug ORAVIG Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Bausch drug VANOS appeared first on DrugPa…
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sunovion Resp drug LONHALA MAGNA…
New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT Read Post »